Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

Sepideh Gholami; Mustafa Abidalhassan; May Cho; Anwaar Saeed; Flavio G Rocha

doi:10.1007/s12029-022-00849-5

Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting

J Gastrointest Cancer. 2023 Jun;54(2):672-676. doi: 10.1007/s12029-022-00849-5. Epub 2022 Jul 19.

Authors

Sepideh Gholami¹, Mustafa Abidalhassan², May Cho³, Anwaar Saeed⁴, Flavio G Rocha⁵

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of California Davis, 2279 45th Street, Sacramento, CA, 95817, USA. sgholami@ucdavis.edu.
² Division of Surgical Oncology, Department of Surgery, University of California Davis, 2279 45th Street, Sacramento, CA, 95817, USA.
³ Division of Medical Oncology, Department of Medicine, University of California Irvine, Irvine, CA, USA.
⁴ Division of Medical Oncology, Department of Medicine, University of Kansas, Kansas City, KS, USA.
⁵ Division of Surgical Oncology, Department of Surgery, Oregon Health Sciences University, Portland, OR, USA.

PMID: 35856132
DOI: 10.1007/s12029-022-00849-5

Abstract

Purpose: To provide an overview of the key findings from studies in upper gastrointestinal, hepatobiliary, pancreas, and colorectal malignancies presented at ASCO GI 2022.

Methods: We reviewed the abstracts presented at ASCO GI 2022. The studies highlighted were selected by the authors based on their significant discoveries and potential impact on clinical practice.

Results and conclusion: This year's hybrid ASCO-GI symposium (2022) introduced many promising new treatment strategies in GI oncology, with several changes in clinical practice for patients with advanced hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic colorectal cancer (CRC).

Keywords: ASCO-GI symposium; Colorectal cancer; Esophygeal cancer; Gastric cancer; Hepatobiliary cancers; Pancreatic cancer.

Publication types

Review

MeSH terms

Bile Duct Neoplasms*
Bile Ducts, Intrahepatic / pathology
Carcinoma, Hepatocellular*
Colorectal Neoplasms* / therapy
Gastrointestinal Neoplasms* / diagnosis
Gastrointestinal Neoplasms* / pathology
Gastrointestinal Neoplasms* / therapy
Humans
Liver Neoplasms* / therapy
Medical Oncology / methods
United States